Literature DB >> 23737417

Child neuropsychopharmacology: good news… the glass is half full.

Celso Arango1.   

Abstract

Entities:  

Year:  2013        PMID： 23737417      PMCID： PMC3683260          DOI： 10.1002/wps.20032

Source DB:  PubMed          Journal:  World Psychiatry        ISSN： 1723-8617            Impact factor:   49.548


× No keyword cloud information.
  6 in total

1.  ECNP Summit on the future of CNS drug research in Europe 2011: report prepared for ECNP by David Nutt and Guy Goodwin.

Authors:  David Nutt; Guy Goodwin
Journal:  Eur Neuropsychopharmacol       Date:  2011-07       Impact factor: 4.600

2.  Child and adolescent neuropsychopharmacology: now or never.

Authors:  Celso Arango
Journal:  Eur Neuropsychopharmacol       Date:  2011-06-12       Impact factor: 4.600

3.  Someone is not listening to the facts: there is little psychiatry outside child and adolescent psychiatry.

Authors:  Celso Arango
Journal:  Eur Child Adolesc Psychiatry       Date:  2012-09       Impact factor: 4.785

Review 4.  Efficacy and safety of second-generation antipsychotics in children and adolescents with psychotic and bipolar spectrum disorders: comprehensive review of prospective head-to-head and placebo-controlled comparisons.

Authors:  David Fraguas; Christoph U Correll; Jessica Merchán-Naranjo; Marta Rapado-Castro; Mara Parellada; Carmen Moreno; Celso Arango
Journal:  Eur Neuropsychopharmacol       Date:  2010-08-10       Impact factor: 4.600

5.  ADHD medication use following FDA risk warnings.

Authors:  Colleen L Barry; Andres Martin; Susan H Busch
Journal:  J Ment Health Policy Econ       Date:  2012-09

6.  National trends in the office-based treatment of children, adolescents, and adults with antipsychotics.

Authors:  Mark Olfson; Carlos Blanco; Shang-Min Liu; Shuai Wang; Christoph U Correll
Journal:  Arch Gen Psychiatry       Date:  2012-12
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.